GPER was reported to induce invasion and proliferation in breast and ovarian cancers; however, it was found to have a cancer-suppressive effect in non-small cell lung cancer, liver cancer, and triple negative breast cancer [19–21]. This evidence concerns the gene GPER1 and triple-negative breast carcinoma.